← Leaderboards
Mo Reza Ebrahimkhani
University Of Pittsburgh At Pittsburgh
$5,509,143
Attributed
$6,192,482
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,192,482 · 4
By mechanism
R01$6,192,482 · 4
Top collaborators
- Michael Oertel2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Erin Rubin$634,230
- Andrew W Duncan$4,424,296
- Chuanyue Wu$7,897,835
- Shiguang Qian$1,273,308
- George K Michalopoulos$12,892,897
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticIn VivoEngineeringInduced Pluripotent Stem CellTissuesIn VitroTechnologyLiverCellsStem CellsGenetic EngineeringProgramsGata6 Transcription FactorSourceFetal LiverClustered Regularly Interspaced Short Palindromic RepeatsCell TypeHuman EngineeringSynthetic BiologyBiologyAdultOrganOrganoidsSynthetic Genes
Grant awards (12)
Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness$683,339
R01 · FY2025 · DK
Integration of Systems and Synthetic Biology to Advance Development of Human Tissues In Vitro$596,431
R01 · FY2025 · DK · contact PI
Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness$683,339
R01 · FY2024 · DK
Integration of Systems and Synthetic Biology to Advance Development of Human Tissues In Vitro$632,676
R01 · FY2024 · DK · contact PI
A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells$539,242
R01 · FY2022 · HL · contact PI
Integration of systems and synthetic biology to advance development of human tissues ex vivo$436,157
R01 · FY2022 · EB · contact PI
A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells$497,846
R01 · FY2021 · HL · contact PI
Integration of systems and synthetic biology to advance development of human tissues ex vivo$416,808
R01 · FY2021 · EB · contact PI
A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells$425,529
R01 · FY2020 · HL · contact PI
Integration of systems and synthetic biology to advance development of human tissues ex vivo$415,024
R01 · FY2020 · EB · contact PI
A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells$439,779
R01 · FY2019 · HL · contact PI
Integration of systems and synthetic biology to advance development of human tissues ex vivo$426,312
R01 · FY2019 · EB · contact PI